S100B and meningioma: The first report investigated serum S100B levels of 50 meningioma patients preoperatively and post-craniotomy for 7 serial days.44 Results showed that augmented S100B had high correlation with larger tumors, intraoperative difficulties, post-craniotomy acute degradation and long-term poor outcome.